Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
9°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gamida Cell Ltd
(NQ:
GMDA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.0305 (20)
Ask (Size)
0.0320 (140)
Prev. Close
0.0327
Today's Range
N/A - N/A
52wk Range
0.0303 - 0.4870
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 05, 2024
It's time to dive into all of the biggest pre-market stock movers that traders will want to keep an eye on Friday morning!
Via
InvestorPlace
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 03, 2024
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...
Via
Benzinga
Exposures
Glyphosate
Performance
More News
Read More
Why Gamida Cell Shares Are Falling Today
March 27, 2024
Via
Benzinga
Gamida Cell Earnings Preview
March 26, 2024
Via
Benzinga
Expert Ratings for Gamida Cell
December 05, 2023
Via
Benzinga
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
April 03, 2024
Via
Benzinga
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
April 01, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
US Stocks Flat; Initial Jobless Claims Fall To 210,000
March 28, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recap: Gamida Cell Q3 Earnings
November 14, 2023
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 28, 2024
Via
Benzinga
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
March 28, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 28, 2024
Via
InvestorPlace
Gold Moves Higher; Velo3D Shares Plummet
March 27, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Edges Lower; PaySign Shares Spike Higher
March 27, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Trump Media (DJT) Stock Jumps 18% in Second Trading Day
March 27, 2024
Via
InvestorPlace
Topics
Government
Exposures
Political
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 27, 2024
Via
Benzinga
GMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023
March 27, 2024
Via
InvestorPlace
Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50%
March 27, 2024
Via
InvestorPlace
Why Is Gamida Cell (GMDA) Stock Down 82% Today?
March 27, 2024
Via
InvestorPlace
Dow Jumps Over 200 Points; UniFirst Posts Downbeat Earnings
March 27, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For March 27, 2024
March 27, 2024
Via
Benzinga
Small-Caps Grossly Underperform Broader Market Amid This Red Flag: 5 Stocks On The Scanner
November 20, 2023
Via
Benzinga
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Via
Benzinga
Gamida Cell's Blood Cancer Candidate Shows Encouraging Anti-Tumor Activity In Heavily Pretreated Patients
October 17, 2023
Via
Benzinga
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
October 16, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.